BCSCDB: Biomarkers of Cancer Stem Cells Database
Number of entries related to MIA-PaCa-3 cell line is 130
| GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NANOG | 20857 | LTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by qPCR and Western Blotting | NA | 0.48 | 0.5461 | 34168259 |
| SOX2 | 11195 | LTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by qPCR and Western Blotting | NA | 0.48 | 0.5695 | 34168259 |
| HNRNPAB | 5034 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.36 | 0.0032 | 34168259 |
| LDHA | 6535 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.36 | 0.0053 | 34168259 |
| VDAC2 | 12672 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.36 | 0.0011 | 34168259 |
| HDHA | NA | HTM/LTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics and Western Blotting | Up | 0.36 | 0.0011 | 34168259 |
| HNRNPAB | 5034 | HTM/LTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics and Western Blotting | Down | 0.36 | 0.0032 | 34168259 |
| LDHA | 6535 | HTM/LTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics and Western Blotting | Down | 0.36 | 0.0053 | 34168259 |
| VDAC2 | 12672 | HTM/LTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics and Western Blotting | Up | 0.36 | 0.0011 | 34168259 |
| CCNB1 | 1579 | LTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by qPCR | NA | 0.2 | 0.0053 | 34168259 |
| FZD2 | 4040 | LTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by qPCR | NA | 0.2 | 0.0021 | 34168259 |
| POU5F1 | 9221 | LTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by qPCR | NA | 0.2 | 0.6448 | 34168259 |
| AARS1 | 20 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259 |
| ACTN4 | 166 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0074 | 34168259 |
| AGPAT1 | 324 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259 |
| AHNAK | 347 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 34168259 |
| AKR1C1 | 384 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0085 | 34168259 |
| ALB | 399 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259 |
| ALDH3A1 | 405 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0074 | 34168259 |
| ALDOA | 414 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 34168259 |
| ALDOC | 418 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259 |
| ARF3 | 654 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259 |
| ATP5F1B | 830 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259 |
| ATP5PO | 850 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259 |
| CACYBP | 30423 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259 |
| CALR | 1455 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259 |
| CANX | 1473 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 34168259 |
| CCT7 | 1622 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259 |
| CLTC | 2092 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 34168259 |
| CMPK1 | 18170 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259 |
| CTSB | 2527 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0053 | 34168259 |
| CTSD | 2529 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0053 | 34168259 |
| DDOST | 2728 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259 |
| DLAT | 2896 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259 |
| DLST | 2911 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259 |
| ECHS1 | 3151 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 34168259 |
| EEF1G | 3213 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259 |
| EIF5A | 3300 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 34168259 |
| EPCAM | 11529 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.211 | 34168259 |
| ETFA | 3481 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259 |
| EZR | 12691 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0064 | 34168259 |
| FASN | 3594 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0074 | 34168259 |
| FKBP1A | 3711 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259 |
| FLNA | 3754 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 34168259 |
| FLNB | 3755 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259 |
| GFPT1 | 4241 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259 |
| H2AC1 | 18729 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259 |
| HADHA | 4801 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 34168259 |
| HBA1 | 4823 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259 |
| HBB | 4827 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259 |
| HMGN2 | 4986 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259 |
| HNRNPD | 5036 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259 |
| HNRNPF | 5039 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259 |
| HNRNPR | 5047 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259 |
| HSD17B10 | 4800 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259 |
| HSD17B12 | 18646 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259 |
| HSP90AB1 | 5258 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0074 | 34168259 |
| HSP90B1 | 12028 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 34168259 |
| HSPA5 | 5238 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0117 | 34168259 |
| HSPA8 | 5241 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0085 | 34168259 |
| HSPA9 | 5244 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 34168259 |
| HYOU1 | 16931 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 34168259 |
| KRT1 | 6412 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 34168259 |
| KRT10 | 6413 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259 |
| KRT18 | 6430 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0074 | 34168259 |
| KRT2 | 6439 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259 |
| KRT9 | 6447 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 34168259 |
| LASP1 | 6513 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259 |
| LGALS1 | 6561 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0053 | 34168259 |
| MGST3 | 7064 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259 |
| MT-CO2 | 7421 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259 |
| MYH9 | 7579 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0064 | 34168259 |
| MYL12A | 16701 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259 |
| NME2 | 7850 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 34168259 |
| NQO1 | 2874 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 34168259 |
| P4HB | 8548 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 34168259 |
| PARK7 | 16369 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259 |
| PCNA | 8729 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259 |
| PHB | 8912 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259 |
| PHB2 | 30306 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259 |
| PPP1CB | 9282 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259 |
| PPP6R2 | 19253 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259 |
| PRDX2 | 9353 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0074 | 34168259 |
| PRDX5 | 9355 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259 |
| PSMB1 | 9537 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259 |
| PTMA | 9623 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259 |
| PYGB | 9723 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259 |
| RBBP7 | 9890 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259 |
| RPL14 | 10305 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259 |
| RPL17 | 10307 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259 |
| RPL23A | 10317 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259 |
| RPL35 | 10344 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259 |
| RPL35A | 10345 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259 |
| RPL5 | 10360 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259 |
| RPN1 | 10381 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 34168259 |
| RPN2 | 10382 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259 |
| RPS14 | 10387 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259 |
| RPS19 | 10402 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259 |
| RPS21 | 10409 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259 |
| RPS26 | 10414 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259 |
| RPS28 | 10418 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259 |
| RPS29 | 10419 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259 |
| RPS5 | 10426 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259 |
| RPS7 | 10440 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259 |
| SAR1B | 10535 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259 |
| SETSIP | 42937 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259 |
| SLC12A2 | 10911 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0053 | 34168259 |
| SLC1A5 | 10943 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259 |
| SLC25A5 | 10991 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259 |
| SLC25A6 | 10992 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259 |
| SLC2A1 | 11005 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 34168259 |
| SQOR | 20390 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259 |
| SRSF1 | 10780 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259 |
| SUMO4 | 21181 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259 |
| SYPL1 | 11507 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259 |
| TAGLN2 | 11554 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259 |
| TCP1 | 11655 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0053 | 34168259 |
| TECR | 4551 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259 |
| TFRC | 11763 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0053 | 34168259 |
| TMPO | 11875 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259 |
| TRAP1 | 16264 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0053 | 34168259 |
| TST | 12388 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259 |
| TUFM | 12420 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 34168259 |
| UGT1A6 | 12538 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259 |
| UQCRB | 12582 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259 |
| UQCRC1 | 12585 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259 |
| VCL | 12665 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259 |
| VCP | 12666 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 34168259 |
| VDAC1 | 12669 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259 |
| YBX2 | 17948 | HTM | Pancreatic Cancer | Carcinoma | MIA-PaCa-3 | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259 |